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Abstract
Background: We investigated the presence and distribution of the sentinel and the non-sentinel
node micrometastases using complete serial sectioning and immunohistochemical staining (IHC),
to inspect whether lymph node micrometastases spread to the sentinel lymph nodes first.
Methods: A total of 35 patients, who underwent gastrectomy with a sentinel lymph node biopsy
for gastric cancer, were enrolled in this study. Total of 1028 lymph nodes of 35 patients having
gastric cancer without metastasis of lymph node by permanent section with hematoxylin and eosin
staining (H&E) were selected. There were 252 sentinel nodes and the other 776 were non-sentinel
nodes. All nodes were sectioned serially and stained alternately with H&E and IHC. Lymph node
micrometastases was defined as proving to be positive first either the IHC or the complete serial
sectioning.
Results: Micrometastases were detected in 4 (11%) of the 35 patients, 6 (0.58%) of 1028 nodes.
Of these 4 patients, 3 had micrometastases exclusively in sentinel nodes, and the other had
micrometastasis in both sentinel and non-sentinel nodes. There was no patient who had the
micrometasitases only in non-sentinel nodes.
Conclusion: These results support the concept that lymph node micrometastasis of gastric cancer
spreads first to sentinel nodes.
Background
The prognosis of patients with gastric cancer is influenced
primarily by the presence of lymph node metastases.
Lymph node metastases in gastric cancer patients with
submucosal invasion occur in 15 to 20% of patients;
therefore, a lymph node dissection may be unnecessary
Published: 30 May 2008
Journal of Experimental & Clinical Cancer Research 2008, 27:7 doi:10.1186/1756-9966-27-
7
Received: 26 April 2008
Accepted: 30 May 2008
This article is available from: http://www.jeccr.com/content/27/1/7
© 2008 Ishii et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Experimental & Clinical Cancer Research 2008, 27:7 http://www.jeccr.com/content/27/1/7
Page 2 of 7
(page number not for citation purposes)
for the remaining 80 to 85% of patients [1]. An accurate
and reliable indicator to predict the absence of lymph
node metastases would eliminate many unnecessary lym-
phadenectomies [1]. Therefore, a preoperative and accu-
rate diagnosis of lymph node metastases remains
important [2-4]. A sentinel node biopsy for gastric cancer
is an intraoperative diagnostic method to detect lymph
node metastases [5-7]. In 1992, Morton et al. [8] intro-
duced the technique of intraoperative dye injection at the
site of melanoma to identify the "sentinel" node, which is
the first node that the afferent lymphatics enter from the
tumor site. Miwa et al. [7,9] employed this type of dye
mapping technique to identify the sentinel nodes of gas-
tric cancer, and reported a high positive predictive value
and accuracy for the sentinel node biopsy of early gastric
cancer. On the other hand, the presence of a micrometas-
tasis in a lymph node is a serious issue for the clinical
application of sentinel node biopsy for early gastric can-
cer. Lymph node micrometastases have been found in
patients determined to be node-negative by routine histo-
logical examination. Previous investigators have reported
that lymph node micrometastases could be detected using
step sectioning, immunohistochemical staining and the
reverse transcriptase-polymerase chain reaction [10-12].
However, there have been a few reports about the distri-
bution of micrometastases in both the sentinel and non-
sentinel nodes in node-negative gastric cancer patients by
routine histologic examination [13-15].
In this study, we retrospectively investigated the presence
and distribution of sentinel and non-sentinel node
micrometastases using complete serial sectioning and
immunohistochemical staining. These technique are the
most accurate methods to detect micrometastases in
nodes so that we could determine whether lymph node
micrometastases had spread to the sentinel lymph nodes
first.
Methods
A sentinel lymph node (SLNs) biopsy for gastric cancer
was performed on 243 patients at the Department of Gas-
troenterologic Surgery, Kanazawa University Hospital
from 1993 to 2002. Before the sentinel node biopsy was
performed, written informed consent was obtained in
accordance with the ethical standards of the Committee
on Human Experimentation of Kanazawa University Hos-
pital. Of these patients, we enrolled 35 who had a cancer
that had invaded to the submucosa or muscularis propria
and had no lymph node metastasis by routine histologic
examination for this study. None of the patients had
received preoperative chemotherapy or radiotherapy.
Based on the Japanese Classification of Gastric Carci-
noma, all 35 patients underwent a sentinel node biopsy
followed by conventional lymphadenectomy for back-up
dissection [16]. A total of 1028 lymph nodes were
removed from the 35 patients. Of these, 252 lymph nodes
were SLNs and the other 776 were non-SLNs. All 252 SLNs
were negative for metastases both on intraoperative fro-
zen-section examination and permanent section with
hematoxylin and eosin staining (H&E). The other 776
nodes were negative for metastases on histological exam-
ination by H&E of multiple step sectioning at 0.2 cm
intervals. The clinicopathologic data were evaluated
according to the Japanese Classification of Gastric Cancer
[16]. The patients characteristics are listed in Table 1. For
detecting the SLNs, we used intraoperative endoscopic
lymphatic mapping (IELM), which consisted of an intra-
operative injection of 0.2 ml of 2% patent blue into the
submucosal layer at four sites around the gastric carci-
noma through a gastroscope [9]. The dye immediately
appeared at the serosal surface and stained the lymphatic
vessels and nodes [5,9]. In this study, the SLN was defined
as the lymph node that stained blue 20 minutes after the
injection. The lymphatic basins were defined as the area
containing the stained lymphatic vessels, and which were
able to be divided into five categories according to the
directions of the arteries surrounded the stomach, as fol-
lows: the left gastric artery area, the right gastric artery
area, the right gastroepiploic artery area, the right gastroe-
piploic artery area and the posterior gastric artery area. The
excised SLNs were sent for frozen-section examination.
The lymph nodes stained with H&E on representative sec-
tions were cut along the plane with the largest diameter
that included the node hilus, and examined intraopera-
tively for metastases.
The remaining frozen tissues were thawed, and the tissues
and non-SLNs were routinely cut at 0.2 cm intervals. Sub-
sequently, the multiple sectioned lymph nodes and
Table 1: Patients characteristics
Median age (range) 62 (37–85)
Sex
Male 23
Female 12
Depth of invasion
SM 24
MP 11
Histological type
Differentiated * 18
Undifferentiated * * 17
Lymphatics invasion
Negative 16
positive 19
Vascular invasion
Negative 30
positive 5
SM, submucosa; MP, muscularis propuria
*The differentiated type;papillary, well and moderately differentiated 
tubular adenocarcinomas
**The undifferentiated type;poorly differentiated adenocarcinoma, 
mucinous adenocarcinoma and signet-ring cell carcinoma.Journal of Experimental & Clinical Cancer Research 2008, 27:7 http://www.jeccr.com/content/27/1/7
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resected specimens were fixed in 10% formalin, processed
through graded ethanol, and embedded in paraffin for
permanent sections. The lymph nodes were stained with
H&E and were examined by two pathologists.
In this study, all resected lymph nodes were sectioned seri-
ally at 25-μm intervals of 4-μm thickness in addition and
either alternately stained with H&E and immunohisto-
chemical staining (IHC) using an anti-cytokeratin anti-
body. The ENVISION technique was used (DAKO,
Carpinteria, CA) for IHC and we used the monoclonal
anti-human cytokeratin 8/18 antibody (Santa Cruz Biote-
chonology, California, USA) [17-19]. All main tumor
specimens from 35 patients were subjected to cytokeratin
staining and were used as a positive control. A lymph
node micrometastasis was defined as a node negative for
metastasis by our routine histologic examination, but pos-
itive by either the IHC or the complete serial sectioning
methods.
Results
The total number of sections examined was 24,094. Of
these, 5986 were SLNs and 18,108 were non-SLNs. Of the
35 patients, 4 (11%) had micrometastases. A micrometas-
tasis was found in 6 of 1028 nodes (0.6%) and 60 sections
(0.3%) of 24,094 (Figs. 1, 2). Of these 6 nodes involving
a micrometastasis, 4 were SLNs and the other 2 were non-
SLNs in the lymphatic basin. No micrometastases were
detected outside the basin (Table 2). The details of the dis-
tribution pattern, location and size of the micrometas-
tases are shown in Tables 3, 4 and 5. Of the 4 patients who
had a lymph node micrometastasis, 3 patients had
micrometastases exclusively in the SLNs. The other patient
had a micrometastasis in both the SLN and non-SLNs in
the lymphatic basin. No patient had a micrometastasis
only in non-SLNs. No patient has yet suffered a recurrence
or has died as of December, 2007.
Discussion
Miwa et al. introduced the concept of sentinel node
biopsy for gastric cancer [7]. The clinical use of the senti-
nel node biopsy to determine the surgical approach for
gastric cancer requires the verification of this concept at
the level of lymph node micrometastases. In this study, we
investigated the presence and distribution of lymph node
micrometastases in patients with gastric cancer who had a
sentinel node biopsy. Recently, the presence of lymph
node micrometastases undetectable by routine histologi-
cal examination has been reported in breast, lung, esopha-
gus, stomach, colon and gallbladder cancers. It has been
reported that a lymph node micrometastasis was a poor
prognostic indicator in breast, lung, and colon cancers
[20-22]. A few authors have reported that a lymph node
micrometastasis was a poor prognostic factor in gastric
cancer patients [23,24]. Thus, the importance of the
detecting a lymph node micrometastasis has been empha-
sized for various neoplastic diseases.
A variety of methods to detect lymph node micrometas-
tases exist, including IHC and polymerase chain reaction
assays. Matsumoto et al. demonstrated that the reverse
transcriptase-polymerase chain reaction (RT-PCR) is more
sensitive than IHC for the detection of micrometastases
[2]. However, Yamamoto et al. [25] suggested that posi-
tive results with a molecular assay such as RT-PCR may
not be indicative of the presence of viable tumor cells, but
rather the presence of tumor DNA and thus, may be asso-
ciated with a greatly increased false positive rate despite
the higher sensitivity of the molecular assay. On the other
hand, it has been reported that the serially sectioning
increased the identification of tumor cells in the periph-
eral sinuses of lymph nodes [26]. It is thought that serial
sectioning with IHC is the most accurate method for the
detection of lymph node micrometastases. Therefore, we
subjected the entire specimen to serial sectioning and
IHC. The antibody used for IHC was a monoclonal anti-
human cytokeratin 8/18 antibody which is more sensi-
tive, specific, simple, accurate, and economic than other
antibodies for IHC.
Tumor deposits within lymph nodes were classified and
staged according to the revised guidelines set by the Inter-
national Union Against Cancer (UICC) 6th  Edition.
According to this classification system, metastases less
Table 2: Number and location of lymph nodes with micrometastasis
Location of nodes Number of nodes
with micrometastasis without micrometastasis
SLNs 4 248
non-SLNs in lymphatic basin 2 653
non-SLNs out of basin 0 121
All nodes 6 1022
SLNs, sentinel lymph nodesJournal of Experimental & Clinical Cancer Research 2008, 27:7 http://www.jeccr.com/content/27/1/7
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than 0.2 cm were considered micrometastases (MMs), and
isolated tumor cells (ITCs) were single tumor cells or
small clusters of cells that measured no greater than 0.2
mm and were usually detected by IHC or molecular meth-
ods, but may be verified with H&E. ITCs do not typically
show evidence of metastatic activity by proliferation,
induction of a stromal reaction, or penetration of vascular
or lymphatic sinus wall invasion [27,28]. Nakajo et al.
[23] and Siewert et al. [29] reported that lymph node
involvement is classified into cluster formation or single
cell forms, according to the results of IHC for cytokeratin.
Their results suggested that single cells cannot proliferate
in lymph nodes because they were already killed by local
and general immunocytes. A cluster of cells with a stromal
reaction may easily proliferate and therefore have meta-
static potential. In our department, resected lymph nodes
are routinely cut at 0.2 cm intervals and the lymph nodes
are examined for metastases. So, in this study, the defini-
tion of lymph node micrometastasis differed from the
UICC classification. For this study it was defined as a
node, negative for metastasis by our routine histological
examination of sections cut at 0.2 cm intervals, but posi-
tive by complete serial sectioning with H&E and IHC. In
addition, all single cell types and small cluster types with-
out a stromal reaction by cytokeratin positive staining
were not recognized as cancer cells in the next H&E
stained slide. Thus, we excluded all single cells and small
clusters without a stromal reaction, which are classified as
ITCs in the UICC classification system, from the positive
lymph node micrometastasis group [27,28].
We excluded the gastric cancer patients whose tumors had
invaded to the mucosa in this study because doing com-
plete serial sectioning and immunohistochemical staining
was a lot of work; in addition, the rate of a lymph node
micrometastasis was low. Accordingly we enrolled 35 who
had a gastric cancer that had invaded to the submucosa or
muscularis propria and had no evidence of a lymph node
metastasis by histologic examination for this study.
In this study, we observed a lymph node micrometastasis
in 4 patients (11%) with a gastric cancer that had invaded
to the submucosa or muscularis propria. In gastric cancer,
Isozaki et al. [30] and Natsugoe et al. [31] reported that
lymph node micrometastases were identified in 10 to
30% of specimens by step-sectioning or IHC. Our results
were the most accurate of all the past studies and proved
the actual circumstances of lymph node micrometastasis
of gastric cancers that had invaded to the submucosa or
muscularis propria.
In this study, we examined the lymph node micrometas-
tases of SLNs and non-SLNs. We found lymph node
micrometastases in the SLNs of 4 patients. One patient
also had a micrometastasis in a non-SLN of the lymphatic
basin, though no micrometastases of non-SLNs were
identified outside the basin. Furthermore, no patient had
a lymph node micrometastasis only in a non-SLN. Our
results revealed that the patients who didn't have a lymph
node micrometastasis in the SLNs also didn't have a
micrometastasis in the non-SLNs. These results may sup-
port the concept that lymph node micrometastases spread
Table 4: Location of lymph node micrometastasis
case Location of tumor Stained lymphatic 
basins
Number of SLNs Number of 
micrometastsis
Station of 
micrometastasis of 
SLNs
Station of 
micrometastasis of non-
SLNs
1 M, Less Left GA 8 1 No.3 LN -
2 M, Post. Left GA Right GEA 5 1 No.3 LN -
3 M, Ant. Left GA 2 1 No.3 LN -
4 M, Less Left GA Right GEA 10 3 No.3 LN No.3 LN
SLNs, sentinel lymph nodes; M, Middle third of the stomach; Less, lesser curvature; Post.; posterior wall; Ant. anterior wall; GA, gastric artery; 
GEA, gastroepiploic artery; No.3 LN, LN along the lesser curvature
Table 3: Distribution pattern of lymph node micrometastasis
Number of cases
Distribution pattern of micrometastasis Routine histological examination complete serial sectioning and IHC
SLNs (-), non-SLNs (-) 35 31
SLNs (+), non-SLNs (-) 0 3
SLNs (+), non-SLNs (+) 0 1
SLNs (-), non-SLNs (+) 0 0
SLNs, sentinel lymph nodes; IHC, immunohistochemic stainingJournal of Experimental & Clinical Cancer Research 2008, 27:7 http://www.jeccr.com/content/27/1/7
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first to the SLNs, then to the non-SLNs in the lymphatic
basin and finally to non-SLNs outside the basin. There-
fore, based upon this concept, it is sufficient to examine
only the SLNs to determine whether or not there are
lymph node micrometastases in patients with gastric can-
cer.
It is still unclear whether a lymph node micrometastasis is
a prognostic factor in gastric cancer. However, a lymph
node micrometastasis was found in gastric cancer patients
who had no evidence of a lymph node metastasis by rou-
tine staining. This result suggests that we should cau-
tiously reduce the extent of lymph node dissections. The
intraoperative absence of a SLN micrometastasis suggests
that the extent of lymph node dissection may be safely
reduced, because it is unlikely for non-SLNs to have
micrometastases without a SLN micrometastasis. In the
case of breast cancer, the need for the intraoperative diag-
nosis of lymph node micrometastases is not essential,
because additional dissection of the axillary lymph nodes
can be performed easily. However, the subsequent dissec-
tion of lymph nodes is difficult in gastric cancer; therefore,
the intraoperative diagnosis of lymph node micrometas-
tases is crucial. We believed that when a lymph node
micrometastasis was present, we should perform a lymph
node dissection at the present. Our study utilized the most
accurate methods, but we could not obtain the results rap-
idly enough for an itraoperative diagnosis. Therefore, we
need to establish an accurate method for rapid intraoper-
ative identification. Matsumoto et al. claimed that intra-
operative rapid immunostaining was a simple and useful
technique for detecting lymph node micrometastases
[32]. An ultra-rapid RT-PCR system, which can complete
the detection of cancer cells within approximately 70 min-
utes, has been developed. In the near future, these meth-
ods will be applied to detect lymph node micrometastases
in SLNs during surgery [33].
Conclusion
we have demonstrated the ability to detect lymph node
micrometastases by subjecting the entire specimen to
complete serial sectioning and IHC for node-negative gas-
tric cancer patients who have had a sentinel node biopsy.
These results support the concept that lymph node
micrometastases spreads first to the SLNs. In addition, the
intraoperative and rapid diagnosis of lymph node
micrometastases in SLNs may help guide the appropriate
lymph node dissection in gastric cancer patients. There-
fore, a rapid and accurate intraoperative diagnosis of
lymph node micrometastases in SLNs will be necessary
and should be the focus of future studies.
Lymph node mircrometastasis as detected by immunohisto- chemical staining with a cytokeratin antibody Figure 1
Lymph node mircrometastasis as detected by immunohisto-
chemical staining with a cytokeratin antibody. (×400).
Table 5: Site and size of lymph node micrometastasis
case Type of lymph node Site in lymph node Size of micrometastasis(mm)
1 SLN peripheral sinus 1.2
2 SLN peripheral sinus 0.3
3 SLN peripheral sinus 0.2
4 SLN peripheral sinus 0.6
non-SLN peripheral sinus 1.0
non-SLN peripheral sinus 1.0
SLN, sentinel lymph nodeJournal of Experimental & Clinical Cancer Research 2008, 27:7 http://www.jeccr.com/content/27/1/7
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